We are looking forward to meeting you and enjoying breakfast whilst listening to some great presentations:
Introduction into the unique world the pillar array column technology: Paul Jacobs (co-founder and COO of PharmaFluidics).
The µPAC design space: LC column performance tailored to specific LC-MS/MS workflow demands: Jeff Op de Beeck (Application Development Manager).
Robust, Deep and Rapid Plasma Proteomics Workflow with Proteograph™Product Suite : Khatereh Motamedchaboki and Jessica Chu, Ph.D.,from Seer.bio. They will be covering:
- Current challenges in scaling plasma proteomics
- An overview of the Proteograph Product Suite
- Comparing the Proteograph platform to alternative workflows
- Robust proteomics workflow for large scale plasma proteomics studies and user’s experience with the µPAC technology
Finally, we will talk you through the latest developments at PharmaFluidics. After sharing some basic principles on how column design affect chromatographic performance, the potential of different column formats for a range of nanoLC separation needs will be discussed together with some recent developments towards ease of use and standardization of µPAC technology.
Paul Jacobs, PhD, has accumulated an extensive expertise in a wide variety of life sciences and medical device technologies, ranging from biosensors to in vitro diagnostic assays, as a research engineer, consultant, and program manager. Paul holds engineering degrees in Physical Electronics from the University of Ghent, and Biomedical Engineering and a Ph.D. in Applied Sciences (Biosensors Development) from the University of Leuven. He is inventor and co-author on several granted patents.
Paul is a co-founder, and currently COO of PharmaFluidics.
Dr. Jeff Op de Beeck was PharmaFluidics’ first full time employee and his Ph.D. work under supervision of Prof. Gert De Smet and Prof. Wim De Malsche formed the basis for the current micro Pillar Array Column, which is branded by PharmaFluidics as the µPAC™. He holds a master’s degree in Biomedical Sciences from the university of Antwerp and a Ph.D. in Chemical Engineering from the university of Brussels. His current position at PharmaFluidics is Application Development Manager.
Khatereh Motamedchaboki is an Associate Director of Product Marketing at Seer, working on cutting-edge proteomics technologies including Proteograph Product Suite, a nanoparticle-based technology for deep plasma proteomics at scale. Prior to Seer, she led single-cell proteomics efforts using LCMS product platforms at Thermo Fisher Scientific. Khatereh built and directed the proteomics core at the NCI-Designated Cancer Center at the Sanford Burnham Prebys Medical Discovery Institute in La Jolla for 10 years. She was a key contributor to development of BioID, a screening method for mapping protein‐protein interactions and an N-terminomics workflow for protease substrate identification. She has industry experience in LCMS integrated solution marketing and many scientific contributions in the fields of targeted proteomics, protein PTM analysis, and protein interactions.
Jessica Chu is a Senior Research Associate at Seer, working cross-functionally between assay development, mass spectrometry, and proteomics data analysis. Jessica started her proteomics journey searching for cancer biomarkers for drug development and joined Seer to help build a plasma proteomics platform.
Please register below to confirm your spot at the breakfast seminar.